Skip to content

Tuesday, July 1, 2025

Latest:

Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

BRCA

Policywise

Direct-to-consumer BRCA testing: Can a reasonable decision still require caution?

March 21, 2018 23andMe, BRCA, genetic testing, health policy, Mary Anderlik Majumder, US FDA

On March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma